newsfilter
← Latest News
GlobeNewswire·

District Court Dismisses Dispute Filed by United Therapeutics Against Liquidia

Court will not hear cross-claim that challenges the PH-ILD indication in the tentatively approved NDA for YUTREPIAFDA can grant final approval of YUTREPIA after blocking regulatory exclusivity expires on May 23, 2025